Abstract
Angiogenesis plays an important role in a wide range of physiological processes. In this paper, we designed and synthesized a series of new analogs including 11 line-peptides and 9 cyclo-peptides by using a marine cyclopeptide (compound 21) which could stimulate angiogenesis on zebrafish in our previous studies as lead compound. The majority of compounds synthesized exhibited angiogenic effects when tested in vivo on zebrafish. Among them, compounds 3, 4, 10, and 15 exhibited much stronger angiogenic activities on zebrafish compared with the lead compound, and the line peptides 3 and 4 showed the most significant angiogenic activities. The SAR (structure-activity relationship) analysis revealed that Val, Lys and Ala are important for the activity. Further studies showed that 3 could concentration-dependently stimulate proliferation, migration and invasion in HUVECs (human umbilical vein endothelial cells) in vitro. To explore the angiogenesis mechanism of this series of compounds, a microarray analysis was carried out to study the gene expression profile and the result showed that 26 genes were upregulated more than 2 fold changes in treatment with 3 on zebrafish, in which mmp9 and mmp13a, two angiogenesis-related genes, increased up to 5-folds. Moreover, through the GO (gene ontology) enrichment analysis, mmp9 and mmp13a genes are the central nodes in the biological processes network. These results suggested that the pro-angiogenic mechanism of this kind of small molecular peptides is related with the expression and regulation of mmp genes in the signal transduction pathways. Additionally, one mmp inhibitor was chosen for further confirmation.
Keywords: Angiogenesis, angiogenic activity, cyclopeptide, gene ontology, human umbilical vein endothelial cells, microarray analysis, mmp, pro-angiogenic mechanism, structure-activity relationship, zebrafish
Current Medicinal Chemistry
Title:Design, SAR, Angiogenic Activities Evaluation and Pro-Angiogenic Mechanism of New Marine Cyclopeptide Analogs
Volume: 20 Issue: 9
Author(s): J. Li, X. Lu, Q. Wu, G. Yu, Z. Xu, L. Qiu, Z. Pei, Y. Lin and J. Pang
Affiliation:
Keywords: Angiogenesis, angiogenic activity, cyclopeptide, gene ontology, human umbilical vein endothelial cells, microarray analysis, mmp, pro-angiogenic mechanism, structure-activity relationship, zebrafish
Abstract: Angiogenesis plays an important role in a wide range of physiological processes. In this paper, we designed and synthesized a series of new analogs including 11 line-peptides and 9 cyclo-peptides by using a marine cyclopeptide (compound 21) which could stimulate angiogenesis on zebrafish in our previous studies as lead compound. The majority of compounds synthesized exhibited angiogenic effects when tested in vivo on zebrafish. Among them, compounds 3, 4, 10, and 15 exhibited much stronger angiogenic activities on zebrafish compared with the lead compound, and the line peptides 3 and 4 showed the most significant angiogenic activities. The SAR (structure-activity relationship) analysis revealed that Val, Lys and Ala are important for the activity. Further studies showed that 3 could concentration-dependently stimulate proliferation, migration and invasion in HUVECs (human umbilical vein endothelial cells) in vitro. To explore the angiogenesis mechanism of this series of compounds, a microarray analysis was carried out to study the gene expression profile and the result showed that 26 genes were upregulated more than 2 fold changes in treatment with 3 on zebrafish, in which mmp9 and mmp13a, two angiogenesis-related genes, increased up to 5-folds. Moreover, through the GO (gene ontology) enrichment analysis, mmp9 and mmp13a genes are the central nodes in the biological processes network. These results suggested that the pro-angiogenic mechanism of this kind of small molecular peptides is related with the expression and regulation of mmp genes in the signal transduction pathways. Additionally, one mmp inhibitor was chosen for further confirmation.
Export Options
About this article
Cite this article as:
Li J., Lu X., Wu Q., Yu G., Xu Z., Qiu L., Pei Z., Lin Y. and Pang J., Design, SAR, Angiogenic Activities Evaluation and Pro-Angiogenic Mechanism of New Marine Cyclopeptide Analogs, Current Medicinal Chemistry 2013; 20 (9) . https://dx.doi.org/10.2174/0929867311320090007
DOI https://dx.doi.org/10.2174/0929867311320090007 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis, Molecular Docking and Dynamics Simulation Studies of New 7-oxycoumarin Derivatives as Potential Antioxidant Agents
Mini-Reviews in Medicinal Chemistry Allosteric Enhancers for A1 Adenosine Receptor
Mini-Reviews in Medicinal Chemistry Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Current Drug Targets Solvent-Free Synthesis and Insecticidal Activities of C6-Esterified Coumarins
Letters in Drug Design & Discovery Toward the Virtual Screening of Potential Drugs in the Homology Modeled NAD+ Dependent DNA Ligase from Mycobacterium tuberculosis
Protein & Peptide Letters Isothiocyanate Synthetic Analogs: Biological Activities, Structure-Activity Relationships and Synthetic Strategies
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Amberlyst-15® in PEG-400: Green Synthesis of 3-Benzoyl-5-Hydroxy Benzofuran and Naphtho[1,2-b]furan Derivatives at Room Temperature
Letters in Organic Chemistry Design, Synthesis, SAR Study, Antimicrobial and Anticancer Evaluation of Novel 2-Mercaptobenzimidazole Azomethine Derivatives
Mini-Reviews in Medicinal Chemistry COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19
Current Medicinal Chemistry Antiobesity Carbonic Anhydrase Inhibitors
Current Topics in Medicinal Chemistry Modulation of Cytochrome-P450 Inhibition (CYP) in Drug Discovery: A Medicinal Chemistry Perspective
Current Medicinal Chemistry High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists
Current Topics in Medicinal Chemistry Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Current Pharmaceutical Design Interleukin-6 Blockers Improve Inflammation-Induced Lipid Metabolism Impairments but Induce Liver Fibrosis in Collagen-Induced Arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Approaches to the Management of Acute Kidney Injury in Children
Recent Patents on Biomarkers Efficient Synthesis of Five and Six Member Sultam
Letters in Organic Chemistry Design and Development of Signal Transduction Inhibitors for Cancer Treatment: Experience and Challenges with Kinase Targets
Current Signal Transduction Therapy Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets